A-262
A-262 (Novichok agent)
A-262 is a chemical compound classified as a nerve agent and is part of the Novichok family of agents. These agents were developed in the Soviet Union during the late stages of the Cold War as part of a program to create more potent chemical weapons that could evade international detection and bans.
Chemical Properties
A-262, like other Novichok agents, is an organophosphate compound. It is designed to inhibit the enzyme acetylcholinesterase, leading to an accumulation of acetylcholine in the synaptic cleft and causing continuous stimulation of muscles, glands, and central nervous system functions.
Mechanism of Action
The primary mechanism of action for A-262 involves the irreversible binding to the active site of acetylcholinesterase. This binding prevents the breakdown of acetylcholine, resulting in prolonged neuromuscular transmission and cholinergic crisis. Symptoms of exposure can include muscle twitching, respiratory failure, convulsions, and potentially death.
Toxicity and Effects
A-262 is highly toxic, with effects similar to other nerve agents such as sarin and VX. Exposure can occur through inhalation, skin contact, or ingestion. The rapid onset of symptoms necessitates immediate medical intervention, typically involving the administration of atropine and pralidoxime to counteract the effects.
History and Development
The development of A-262 and other Novichok agents was part of a clandestine effort by the Soviet Union to create chemical weapons that could bypass existing arms control measures. The existence of these agents was not widely known until the 1990s, when former Soviet scientist Vil Mirzayanov revealed details about the program.
Detection and Decontamination
Detection of A-262 requires specialized equipment capable of identifying trace amounts of the compound. Decontamination procedures involve the use of reactive skin decontamination lotion (RSDL) and other chemical neutralizers to remove the agent from surfaces and skin.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD